To the Editor: Translocation t(9;22)(q34;q11) is found in 1-2% of newly diagnosed patients with de novo AML. The prognosis of Ph รพ AML is very poor with a median survival time of only 7 months. We present two patients with de novo Ph รพ AML who received induction chemotherapy and post-remission imati
An uncommon morphological variant of acute promyelocytic leukemia
โ Scribed by Elizabeth Jacob; Amita Ranger; Mamta Sohal; Barbara J. Bain
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 438 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The existence of two distinct subtypes of acute promyelocytic leukemia was confirmed and characterized based on morphologic features of leukemic cells in a series of 63 patients studied by the Cancer and Leukemia Group B (CALGB). Seventeen patients (27%) had microgranular leukemic cells (M3V), and 4
The primary cytogenetic abnormality in acute promyelocytic leukemia (APL; FAB M3) is a reciprocal translocation, t( 15; I7)(q22;q I2), which serves t o fuse the PML gene on chromosome I5 t o the retinoic acid receptor alpha (RAM) gene on chromosome 17. A PML-MM fusion message transcribed from the de
Early diagnosis of t(15;17) acute promyelocytic leukemia (APL) is essential because of the associated disseminated intravascular coagulation and the unique response of the disease to all-trans retinoic acid (ATRA) therapy. Early diagnosis depends primarily on morphological recognition. The French-Am
We present a patient with APL because of the therapeutic implications of the singular chromosomal rearrangement present in his leukemic cells. Our patient is a 60-year-old male who presented with easy bruisability, gum bleeding, weakness, decreased appetite, and night sweats. He is a retired admiral